Literature DB >> 30770990

Risk of adverse pregnancy outcomes by pre-pregnancy Body Mass Index among Italian population: a retrospective population-based cohort study on 27,807 deliveries.

Bianca Masturzo1, Vera Franzè1, Chiara Germano1, Rossella Attini1, Gianluca Gennarelli1, Antonella Lezo1, Alessandro Rolfo1, Claudio Plazzotta1, Elena Brunelli2, Aly Youssef2, Tullia Todros1, Antonio Farina3.   

Abstract

PURPOSE: To estimate the impact of increasing pre-pregnancy Body Mass Index (BMI) on the risk of adverse maternal and perinatal outcomes, in patients who delivered in an Italian tertiary care Obstetric department.
METHODS: Data, related to women who delivered at Sant'Anna Hospital, Turin, between 2011 and 2015, were collected retrospectively from the hospital database. According to BMI, women were considered as normal weight, overweight, and class 1, 2 and 3 obese (WHO criteria). Logistic regression analysis studied the impact of BMI on maternal and neonatal outcomes, adjusting results for maternal age and parity. Adjusted absolute risks of each outcome were reported according to incremental values in pre-pregnancy BMI.
RESULTS: A total of 27,807 women were included. 75.8% of pregnancies occurred among normal-weight women, whereas 16.7% were overweight, and 7.5% obese women (5.4% class 1, 1.7% class 2 and 0.4% class 3). A 10% decrease in pre-pregnancy BMI was associated with a reduction of at least 15% of Gestational diabetes mellitus (GDM), preeclampsia, maternal admission to intensive care unit (ICU), macrosomia, APGAR 5' < 6 and neonatal admission to ICU. GDM and preeclampsia resulted in the highest reduction being almost 30%. Larger differences in BMI (20-25%) corresponded to at least a 10% in reduction of risk of preterm and very preterm delivery and emergency cesarean section. Differences in maternal pre-pregnancy BMI had no impact on the frequency of shoulder dystocia and stillbirth.
CONCLUSIONS: This study offers a quantitative estimation of negative impact of pre-pregnancy obesity on the most common pregnancy and perinatal complications.

Entities:  

Keywords:  Logistic regression; Obesity; Pre-pregnancy BMI; Risk of adverse outcomes

Mesh:

Year:  2019        PMID: 30770990     DOI: 10.1007/s00404-019-05093-0

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  5 in total

1.  Perinatal Outcomes and Risk Factors for Preterm Birth in Twin Pregnancies in a Chinese Population: A Multi-center Retrospective Study.

Authors:  Sijian Li; Jinsong Gao; Juntao Liu; Jing Hu; Xiaoxu Chen; Jing He; Yabing Tang; Xinghui Liu; Yinli Cao
Journal:  Front Med (Lausanne)       Date:  2021-04-21

2.  The influence of advanced age and obesity on pregnancy course and outcome in patients with diabetes mellitus.

Authors:  Gauri Bapayeva; Sanja Terzic; Jelena Dotlic; Karlygash Togyzbayeva; Ulzhan Bugibaeva; Madina Mustafinova; Asem Alisheva; Erbil Karaman; Milan Terzic; Antonio Simone Laganà
Journal:  Prz Menopauzalny       Date:  2022-05-18

3.  Epidemiology of pre-pregnancy body mass index (BMI) among mothers in Abu Dhabi, the United Arab Emirates.

Authors:  Zainab Taha; Ahmed Ali Hassan; Dimitrios Papandreou
Journal:  Front Glob Womens Health       Date:  2022-09-13

4.  Pregnancy in Charcot-Marie-Tooth disease: Data from the Italian CMT national registry.

Authors:  Chiara Pisciotta; Daniela Calabrese; Lucio Santoro; Irene Tramacere; Fiore Manganelli; Gian Maria Fabrizi; Angelo Schenone; Tiziana Cavallaro; Marina Grandis; Stefano C Previtali; Isabella Allegri; Luca Padua; Costanza Pazzaglia; Paola Saveri; Aldo Quattrone; Paola Valentino; Stefano Tozza; Luca Gentile; Massimo Russo; Anna Mazzeo; Maria Claudia Trapasso; Fabio Parazzini; Giuseppe Vita; Davide Pareyson
Journal:  Neurology       Date:  2020-09-14       Impact factor: 9.910

5.  Gestational Diabetes Mellitus in Europe: A Systematic Review and Meta-Analysis of Prevalence Studies.

Authors:  Marília Silva Paulo; Noor Motea Abdo; Rita Bettencourt-Silva; Rami H Al-Rifai
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-09       Impact factor: 6.055

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.